A concise but comprehensive pocket handbook that provides an accessible and up-to-date introductory overview of this debilitating skin disease. Written by highly recognizable leaders in the field, this book presents essential information on the pathophysiology, clinical presentation, diagnosis and management strategies and options for hidradenitis suppurativa, forming an ideal resource to increase awareness of this disease among healthcare professionals.

Alexa Boer Kimball,MD, MPH, is President and Chief Executive Officer of Harvard Medical Faculty Physicians (HMFP), an academic multi-specialty group practice composed of Harvard Medical School (HMS) faculty members at Beth Israel Deaconess Medical Center (BIDMC). A Professor of Dermatology at Harvard Medical School, Dr. Kimballs areas of research include psoriasis and hidradenitis suppurativa.She has published over 275 papers, is the author of the book 100 Questions and Answers about Psoriasis, which has been translated into Spanish, Greek, and Korean, and editor of Dermatologic Diseases and Cumulative Life Course Impairment. Dr. Kimball is widely recognized for her research on physician workforce economics, quality of life, and outcomes, for which she was awarded the American Skin Association Research Award for Health Policy and Medical Education and the Massachusetts General Hospital Bowditch Prize for increasing quality of care while reducing costs.Dr. Kimball has served on multiple non-profit boards including the Society for Investigative Dermatology, where she was elected vice president; the Massachusetts Foundation for the Humanities and Public Policy; and the Hidradenitis Suppurativa Foundation. She is also President of the International Psoriasis Council and actively involved in the philanthropic campaigns of several non-profit scientific and medical organizations.Dr. Kimball received her MD from the Yale School of Medicine, her MPH from the Johns Hopkins Bloomberg School of Public Health, and dual bachelor's degrees in molecular biology and public and international affairs from Princeton University. She completed an internship in medicine at the then-Beth Israel Hospital, her residency in dermatology at Stanford University Medical Center and a clinical research fellowship at the National Institutes of Health.Gregor B.E. Jemec,MD, DMSc, is the founding Chairman at the Department of Dermatology, Zealand University Hospital and fullProfessor at the Health Sciences Faculty of the University of Copenhagen, Denmark. He has broad academic interests in many fields of dermatology and one of his main areas of interest is hidradenitis suppurativa. He was awarded his medical doctorate for early research into hidradenitis by the University of Copenhagen in 1998, and the Inaugural Hidradenitis Suppurativa Foundation Outstanding Investigator award by the Hidradenitis Suppurativa Foundation at the First International Research meeting on Hidradenitis Suppurativa in Dessau, Germany 2006.

Editor biographies vii1 Disease Overview 1.1 Definition 1.2 Epidemiology 1.3 Risk factors 1.4 Mortality, morbidity, and quality of life References 2 Clinical Presentation of Hidradenitis Suppurativa 2.1 Clinical presentation 2.2 Types of lesions 2.3 Involved areas 2.4 Clinical course 2.5 Prognosis and disease complications 2.6 Comorbidities and systemic associations References 3 Pathophysiology of Hidradenitis Suppurativa 3.1 Pathogenesis 3.2 Genetics 3.3 External factors 3.4 Mechanical factors 3.5 Endocrinology3.6 Inflammation 3.7 The role of bacteria3.8 Immune dysregulation 3.9 Key points References4 Diagnostic Workup 4.1 Introduction4.2 Classification systems 4.3 Delay in diagnosis 4.4. Differential diagnosis4.5 Referral criteria References 5 Treatment of Hidradenitis Suppurativa 5.1 Introduction 5.2 Preventative measures& lifestyle modifications 5.3 Medical management 5.4 Radiotherapy 5.5 Light and laser therapy 5.6 Surgery 5.7 Conclusion References